Joseph W. Venslavsky

Author

New Frontier

Also Known As

J. VENSLAVSKY, J. Venslavsky, J. W. VENSLAVSKY, Joseph Venslavsky, Joseph W. Venslavsky

Publications

749

Citations

H-Index

Concepts

All Affiliations

New Frontier GlaxoSmithKline (United States)South College

About

Joseph W. Venslavsky is an author at New Frontier specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	606
2	Biochemistry	4	4	368
3	Natural Sciences	3	3	356
4	Allergy	1	1	116
5	Biomedical Engineering	1	1	28

Joseph W. Venslavsky

Publications

704

Citations

H-Index

Page 1

	Year	Citations
Identification of 4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3<i>S</i>)-3-piperidinylmethyl]oxy}-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-4-yl)-2-methyl-3-butyn-2-ol (GSK690693), a Novel Inhibitor of AKT Kinase Dirk A. Heerding, Nelson Rhodes, Jack D. Leber, Journal of Medicinal Chemistry Cell DeathAkt KinaseMolecular PharmacologyMedicinal ChemistryReceptor Tyrosine Kinase	2008	154
Orally Active and Potent Inhibitors of γ-Aminobutyric Acid Uptake Fadia E. Ali, William E. Bondinell, Penelope A. Dandridge, Journal of Medicinal Chemistry PharmacotherapyExperimental PharmacologyMolecular PharmacologyMedicinal ChemistryGaba Uptake	1985	130
Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic William H. Miller, Doreen Alberts, Pradip K. Bhatnagar, Journal of Medicinal Chemistry PharmacotherapyExperimental PharmacologyPharmacodynamic ModelingTranslational PharmacologyPre-clinical Pharmacology	1999	116
Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists James M. Samanen, Fadia E. Ali, Linda S. Barton, Journal of Medicinal Chemistry Altmetric Attention ScorePharmacotherapyExperimental PharmacologyPharmacodynamic ModelingTranslational Pharmacology	1996	72
Conformational Preferences in a Benzodiazepine Series of Potent Nonpeptide Fibrinogen Receptor Antagonists Richard M. Keenan, James F. Callahan, James M. Samanen, Journal of Medicinal Chemistry	1999	53
New Benzylidenethiazolidinediones as Antibacterial Agents Dirk A. Heerding, Lisa T. Christmann, Tammy J. Clark, Bioorganic & Medicinal Chemistry Letters Bioorganic ChemistryAntibioticsMedicineAntibacterial AgentAntimicrobial Therapy	2003	50
Antiparasitic agents. 6. Synthesis and anthelmintic activities of novel isothiocyanatophenyl-1,2,4-oxadiazoles R. D. HAUGWITZ, A. J. Martínez, Joseph W. Venslavsky, Journal of Medicinal Chemistry Parasitic DiseaseAntiparasitic AgentPathologyOrganic ChemistryHeterocycle Chemistry	1985	44
Design of a potent and orally active nonpeptide platelet fibrinogen receptor (GPIIb/IIIa) antagonist William E. Bondinell, Richard M. Keenan, William H. Miller, Bioorganic & Medicinal Chemistry ThrombopoiesisThrombosisSignal TransductionBlood PlateletMedicine	1994	28
Synthesis and dopaminergic activity of some halogenated mono- and dihydroxylated 2-aminotetralins Joseph Weinstock, Dimitri E. Gaitanopoulos, Hye Ja Oh, Journal of Medicinal Chemistry	1986	26
An alternate enantiospecific synthesis of methyl (S)-7-tert-butoxycarbonyl-2,3,4,5-tetrahydro-4-methyl-3-oxo-1H-1,4-benzodiazepine-2-acetate Thomas W. Ku, Fadia E. Ali, William E. Bondinell, Tetrahedron Letters Organic ChemistryAlternate Enantiospecific SynthesisChemistryAsymmetric CatalysisEnantioselective Synthesis	1997	19

Page 1